255 related articles for article (PubMed ID: 20300067)
1. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.
Trask AJ; Groban L; Westwood BM; Varagic J; Ganten D; Gallagher PE; Chappell MC; Ferrario CM
Am J Hypertens; 2010 Jun; 23(6):687-93. PubMed ID: 20300067
[TBL] [Abstract][Full Text] [Related]
2. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
Trask AJ; Averill DB; Ganten D; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3019-24. PubMed ID: 17308000
[TBL] [Abstract][Full Text] [Related]
3. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
Ye M; Wysocki J; Gonzalez-Pacheco FR; Salem M; Evora K; Garcia-Halpin L; Poglitsch M; Schuster M; Batlle D
Hypertension; 2012 Sep; 60(3):730-40. PubMed ID: 22777933
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
5. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.
Garabelli PJ; Modrall JG; Penninger JM; Ferrario CM; Chappell MC
Exp Physiol; 2008 May; 93(5):613-21. PubMed ID: 18356559
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D
Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061
[TBL] [Abstract][Full Text] [Related]
10. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
Herath CB; Lubel JS; Jia Z; Velkoska E; Casley D; Brown L; Tikellis C; Burrell LM; Angus PW
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G98-G106. PubMed ID: 19389807
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
12. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
13. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
14. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
[TBL] [Abstract][Full Text] [Related]
15. Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7).
Peng WW; Hong L; Liu GY; Lin C; Zhao XL; Wang SZ; Lin L; Pan YX
Hypertens Res; 2019 Nov; 42(11):1745-1756. PubMed ID: 31273339
[TBL] [Abstract][Full Text] [Related]
16. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
Grobe N; Weir NM; Leiva O; Ong FS; Bernstein KE; Schmaier AH; Morris M; Elased KM
Am J Physiol Cell Physiol; 2013 May; 304(10):C945-53. PubMed ID: 23392115
[TBL] [Abstract][Full Text] [Related]
17. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
Bürgelová M; Vanourková Z; Thumová M; Dvorák P; Opocenský M; Kramer HJ; Zelízko M; Malý J; Bader M; Cervenka L
J Hypertens; 2009 Oct; 27(10):1988-2000. PubMed ID: 19593210
[TBL] [Abstract][Full Text] [Related]
18. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
Leenen FH; White R; Yuan B
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406
[TBL] [Abstract][Full Text] [Related]
19. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
Feng Y; Hans C; McIlwain E; Varner KJ; Lazartigues E
PLoS One; 2012; 7(11):e48910. PubMed ID: 23155428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
